4503:TYO
Astellas Pharma Inc
Â¥2,399.00
arrow_upward
+1.70%(+40.00) 1D
Sep 25, 3:30:00 PM GMT+9 · JPY
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4503...
Open
Â¥2,389
High
Â¥2,413
Low
Â¥2,379
Mkt. cap
4.34T
Avg. vol.
5.82M
Volume
5.63M
Dividend
3.25%
Quarterly dividend
Â¥19
Ex-dividend date
Sep 29, 2026
P/E ratio
11.78
52-wk high
Â¥2,717
52-wk low
Â¥1,558
EPS
Â¥204
Shares outstanding
1.92B
No. of employees
14K
Open
Â¥2,389
High
Â¥2,413
Low
Â¥2,379
Mkt. cap
4.34T
Avg. vol.
5.82M
Volume
5.63M
Dividend
3.25%
Quarterly dividend
Â¥19
Ex-dividend date
Sep 29, 2026
P/E ratio
11.78
52-wk high
Â¥2,717
52-wk low
Â¥1,558
EPS
Â¥204
Shares outstanding
1.92B
No. of employees
14K
News stories
From web sources and news partners
Crain's Chicago Business
·
2 days ago
Drugmaker Astellas looks to sell U.S. headquarters in Northbrook
Profile
Astellas Pharma Inc. is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd.
Astellas is a member of the Mitsubishi UFJ Financial Group keiretsu. Wikipedia
About Astellas Pharma Inc
CEONaoki Okamura
Employees14.1K
FoundedApr 1, 2005
HeadquartersChuo City, Tokyo, Japan
SectorPharmaceutical industry
Websiteastellas.com